Furthermore, Si-CDK5 attenuated IL-1β level (Figure 10E), whereas it did not affect TNF-α (Figure 10D) or IL-6 levels (Figure 10F) in NC and miR-125b inhibitor–treated PC-12 cellular AD models. This evidence concerns the gene IL6 and Alzheimer disease.